Clinical Trial Update: Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vaginal versus intramuscular progesterone for preventing recurrent preterm birth has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• 17-alpha-hydroxyprogesterone caproate (17-alpha-hydroxyprogesterone caproate)
• Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Premature Birth | Phase 4 | Status: COMPLETED | Results posted: 2026-02-24